To the Editor: Heyland and colleagues, on behalf of the Canadian Critical Care Trials Group (Dec. 21 issue),¹ report on the comparison between bronchoalveolar lavage and endotracheal aspiration for the diagnosis of ventilator-associated pneumonia. The ...

To the Editor: In the trial reported by Geyer et al. (Dec. 28 issue),¹ which compared capecitabine alone with a combination of lapatinib and capecitabine in women with HER2-positive advanced breast cancer, approximately 60% of patients had received ...

To the Editor: Wang et al. (Dec. 21 issue)¹ suggest that novel biomarkers in aggregate have little influence on the prediction of first cardiovascular events or death. We wonder whether there were sufficient analyses to warrant this conclusion. As ...

To the Editor: Bradley et al. (Nov. 30 issue)¹ have analyzed strategies to reduce the interval between arrival at the hospital and intracoronary balloon inflation (door-to-balloon time) in primary angioplasty in a large multicenter series. However, use ...

To the Editor: In their Medical Progress article on Whipple's disease, Fenollar and colleagues (Jan. 4 issue)¹ raise important issues regarding culture-negative endocarditis. We report on a 38-year-old-man with a 6-month history of polyarthralgia. He had ...

To the Editor: A letter that I submitted to the Journal was published in the January 25 issue.¹ Because there has been concern about the provenance and authorship of that letter, I request that it be retracted.

To the Editor: The use of voriconazole has become common for the management of invasive aspergillosis. However, therapy with voriconazole still sometimes fails, more often because of unresponsive underlying disease than because of resistance of the ...